Login / Signup
Ivvone Zhou
ORCID
Publication Activity (10 Years)
Years Active: 2023-2024
Publications (10 Years): 8
Top Topics
Study Protocol
Phase Ii
Clinical Trial
Top Venues
Clinical cancer research : an official journal of the American Association for Cancer Research
medRxiv : the preprint server for health sciences
</>
This page only lists publications with an associated author ORCID identifier.
Publications
</>
Ivvone Zhou
,
Deborah Plana
,
Adam C Palmer
Tumor-Specific Activity of Precision Medicines in the NCI-MATCH Trial.
Clinical cancer research : an official journal of the American Association for Cancer Research
30 (4) (2024)
Ivvone Zhou
,
Deborah Plana
,
Adam C Palmer
Tumor-Specific Activity of Precision Medicines in the NCI-MATCH Trial.
Clinical cancer research : an official journal of the American Association for Cancer Research
30 (4) (2024)
Ivvone Zhou
,
Deborah Plana
,
Adam C Palmer
Tumor-Specific Activity of Precision Medicines in the NCI-MATCH Trial.
Clinical cancer research : an official journal of the American Association for Cancer Research
30 (4) (2024)
Ivvone Zhou
,
Deborah Plana
,
Adam C Palmer
Tumor-Specific Activity of Precision Medicines in the NCI-MATCH Trial.
Clinical cancer research : an official journal of the American Association for Cancer Research
30 (4) (2024)
Ivvone Zhou
,
Deborah Plana
,
Adam C Palmer
Tumor-Specific Activity of Precision Medicines in the NCI-MATCH Trial.
Clinical cancer research : an official journal of the American Association for Cancer Research
30 (4) (2024)
Ivvone Zhou
,
Deborah Plana
,
Adam C Palmer
Tumor-specific activity of precision medicines in the NCI-MATCH trial.
Clinical cancer research : an official journal of the American Association for Cancer Research
(2023)
Ivvone Zhou
,
Deborah Plana
,
Adam C Palmer
Tumor-specific activity of precision medicines in the NCI-MATCH trial.
Clinical cancer research : an official journal of the American Association for Cancer Research
(2023)
Ivvone Zhou
,
Deborah Plana
,
Adam C Palmer
Tumor-specific activity of precision medicines in the NCI-MATCH trial.
medRxiv : the preprint server for health sciences
(2023)